CRESCENT BIOPHARMA, INC.

SEC 4 · Filed

0001628280-26-040582Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 2, 2026

Grant, award or other acquisition by Lubner David Charles

Security
Stock Option (Right to Buy)
Code
A
Shares
11,050
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-02",
  "direction": "A",
  "exercise_price": "17.01",
  "expiration": "2036-06-02",
  "footnotes": {
    "F1": "This option represents a right to purchase 11,050 of the Issuer\u0027s ordinary shares and vests in full on the earlier of (i) June 2, 2027 or (ii) the date of the Issuer\u0027s next annual meeting of shareholders, in each case, subject to the Reporting Person\u0027s continued service to the Issuer."
  },
  "owners": [
    {
      "cik": "0001572000",
      "name": "Lubner David Charles",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "11050",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "11050",
  "table": "II",
  "underlying_security": "Ordinary Shares",
  "underlying_shares": "11050"
}